The value of PSMA PET for risk stratification in prostate cancer: an update and future aspects

Authors:

Abstract
No abstract available
Funding Information
  • Innovative Health Initiative
  • Prostate Cancer Foundation (22TACT01)
  • Prostate Cancer Foundation (101172722)
  • Prostate Cancer Foundation (101172788)
  • AstraZeneca (95663957)
  • Deutsche Forschungsgemeinschaft (FE1573/7-1 / 714209)

This publication has 39 references indexed in Scilit: